2025. Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety. Biomolecules and Biomedicine. 25, 9 (Aug. 2025), 2127–2138. DOI:https://doi.org/10.17305/bb.2025.11806.